{"title":"慢性髓性白血病干扰素治疗后细胞遗传学完全应答期间发生妊娠。","authors":"L Longree, P Pautier, F Guilhot, P Brice","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A 25 year old woman with chronic myelogenous leukaemia was treated for 27 months with alpha-interferon, leading to complete haematological and cytogenetic remission. One year after interruption of treatment, she became pregnant and delivered a healthy full term infant. This case provides further evidence in support of the safety of alpha-interferon with respect to the fertility of women of childbearing age.</p>","PeriodicalId":19366,"journal":{"name":"Nouvelle revue francaise d'hematologie","volume":"37 4","pages":"249-50"},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pregnancy occurring during complete cytogenetic response after interferon therapy in chronic myeloid leukaemia.\",\"authors\":\"L Longree, P Pautier, F Guilhot, P Brice\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A 25 year old woman with chronic myelogenous leukaemia was treated for 27 months with alpha-interferon, leading to complete haematological and cytogenetic remission. One year after interruption of treatment, she became pregnant and delivered a healthy full term infant. This case provides further evidence in support of the safety of alpha-interferon with respect to the fertility of women of childbearing age.</p>\",\"PeriodicalId\":19366,\"journal\":{\"name\":\"Nouvelle revue francaise d'hematologie\",\"volume\":\"37 4\",\"pages\":\"249-50\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nouvelle revue francaise d'hematologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nouvelle revue francaise d'hematologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pregnancy occurring during complete cytogenetic response after interferon therapy in chronic myeloid leukaemia.
A 25 year old woman with chronic myelogenous leukaemia was treated for 27 months with alpha-interferon, leading to complete haematological and cytogenetic remission. One year after interruption of treatment, she became pregnant and delivered a healthy full term infant. This case provides further evidence in support of the safety of alpha-interferon with respect to the fertility of women of childbearing age.